Administration of AG490 Decreases the Senescence of Umbilical Cord-Mesenchymal Stem Cells and Promotes the Cytotherapeutic Effect in Liver Fibrosis

Researchers uncovered the fate of transplanted MSCs and develop targeting strategies that could enhance the therapeutic efficacy of MSC therapy in liver fibrosis. They used human umbilical cord-MSCs as the study object.